MRI直线加速器弥散加权成像识别胶质母细胞瘤放化疗期间不良预后肿瘤区域
研究纳入75例胶质母细胞瘤放化疗患者(32例在1.5T MRI直线加速器治疗,28例有额外MR-Linac DWI序列),评估MR-Linac DWI能否评估治疗反应并与对比增强GTV变化比较预后价值。结果显示MR-Linac低ADC变化对总生存有预后价值,MR-sim低ADC变化与OS和PFS的相关性优于GTV变化。
要点
- MR-Linac DWI可测量低ADC肿瘤体积,其与OS和PFS的相关性优于对比增强GTV。
- MR-Linac第2至5周(含)低ADC变化对OS有预后价值(风险比下限≥1.2,P值≤0.02)。
- MR-sim第2周低ADC的OS风险比为3.4(P<0.001),GTV为2.0(P=0.022)。
核心结论
- MR-Linac DWI可测量与OS和PFS相关性优于对比增强GTV的低ADC肿瘤体积。
- 低ADC区域可作为剂量提升靶区。
研究设计与样本
- 75例胶质母细胞瘤患者接受放化疗,其中32例在1.5 T MRI直线加速器(MR-Linac)上治疗。
- 患者在放疗计划时及治疗开始后第2、4、10周接受模拟MRI扫描仪(MR-sim)成像。
- 28例患者有额外MR-Linac DWI序列。
- 采用Cox模型评估总生存(OS)和无进展生存(PFS)与临床变量及GTV和低ADC区域(GTV内ADC<1.25 µm2/ms)体积变化的相关性。
主要发现
- 共分析479个MR-Linac DWI数据集和289个MR-sim DWI数据集。
- MR-Linac第2至5周(含)低ADC变化对OS有预后价值(风险比下限≥1.2,P值≤0.02)。
- MR-sim低ADC变化与OS和PFS的相关性大于GTV变化,例如第2周OS风险比低ADC为3.4(P<0.001),GTV为2.0(P=0.022)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Survival in glioblastoma might be extended by escalating the radiotherapy dose to treatment-resistant tumour and adapting to tumour changes. Diffusion-weighted imaging (DWI) on MRI-linear accelerators (MR-Linacs) could be used to identify a dose escalation target, but its prognostic value must be demonstrated. The purpose of this study was to determine whether MR-Linac DWI can assess treatment response in glioblastoma and whether changes in DWI show greater prognostic value than changes in the contrast-enhancing gross tumour volume (GTV). MATERIALS AND METHODS: Seventy-five patients with glioblastoma were treated with chemoradiotherapy, of which 32 were treated on a 1.5 T MRI-linear accelerator (MR-Linac). Patients were imaged with simulation MRI scanners (MR-sim) at treatment planning and weeks 2, 4, and 10 after treatment start. Twenty-eight patients had additional MR-Linac DWI sequences. Cox modelling was used to evaluate the correlation of overall and progression-free survival (OS and PFS) with clinical variables and volumetric changes in the GTV and low-ADC regions (ADC < 1.25 µm2/ms within GTV). RESULTS: In total, 479 MR-Linac DWI and 289 MR-sim DWI datasets were analyzed. MR-Linac low-ADC changes between weeks 2 and 5 inclusive were prognostic for OS (hazard ratio lower limits ≥ 1.2, p-values ≤ 0.02). MR-sim low-ADC changes showed greater correlation with OS and PFS than GTV changes (e.g., OS hazard ratio at week 2 was 3.4 (p <0.001) for low-ADC versus 2.0 (p = 0.022) for GTV). CONCLUSION: MR-Linac DWI can measure low-ADC tumour volumes that correlate with OS and PFS better than contrast-enhancing GTV. Low-ADC regions could serve as dose escalation targets.
引用
- Lawrence LSP, Chan RW, Chen H, et al. Diffusion-weighted imaging on an MRI-linear accelerator to identify adversely prognostic tumour regions in glioblastoma during chemoradiation. Radiother Oncol. 2023. PMID: 37640160. doi:10.1016/j.radonc.2023.109873
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。